Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
5 clinical trials · Condition
◉ Watch Recurrent Lung Non-Squamous Non-Small Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) (NCT04625647) | SWOG Cancer Research Network | 2021-04-16 |
| Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer (NCT04181060) | National Cancer Institute (NCI) | 2020-12-28 |
| Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer (NCT04310007) | National Cancer Institute (NCI) | 2020-07-13 |
| Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial) (NCT04173507) | SWOG Cancer Research Network | 2020-02-14 |
| Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer (NCT03468985) | National Cancer Institute (NCI) | 2018-05-07 |
Track Recurrent Lung Non-Squamous Non-Small Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.